- Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
-
Kang YM, Jung CH
- KMID: 2308856
- Endocrinol Metab.
- 2016 Jun;31(2):258-274.
- doi: 10.3803/EnM.2016.31.2.258
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and beta-Cell Growth
-
Kim HY, Hwang JI, Moon MJ, Seong JY
- KMID: 2169469
- Endocrinol Metab.
- 2014 Sep;29(3):320-327.
- doi: 10.3803/EnM.2014.29.3.320
BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by cleavage of proglucagon in intestinal L-cells. In the pancreas, GLP-1 stimulates post-prandial insulin secretion, promotes insulin biosynthesis, and improves insulin... -
- CITED
-
- Close
- SHARE
-
- Close
